Brimonidine Tartrate NDC 61314-144

NDC codes

FDA NDC Directory

Product NDC (as listed)61314-144Labeler and product segments. Claims need a package NDC.

Product NDC at billing width61314-0144Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
61314-144-05	61314014405	1 BOTTLE in 1 CARTON (61314-144-05) / 5 mL in 1 BOTTLEMarketed from Oct 2, 2010
61314-144-10	61314014410	1 BOTTLE in 1 CARTON (61314-144-10) / 10 mL in 1 BOTTLEMarketed from Oct 2, 2010
61314-144-15	61314014415	1 BOTTLE in 1 CARTON (61314-144-15) / 15 mL in 1 BOTTLEMarketed from Oct 2, 2010

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Brimonidine Tartrate
Generic name (nonproprietary): brimonidine tartrate
Active ingredients: Brimonidine tartrate — 1.5 mg/mL
Dosage form: Solution
Route: Ophthalmic
Labeler: Sandoz Inc
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 021764
Marketing start: Oct 2, 2010
Listing expires: Dec 31, 2026
Other FDA classes: Adrenergic alpha-Agonists (Mechanism)
Identifiers: Product ID 61314-144_6a98ed35-7065-4099-aefc-6d22e674ef55SPL ID 6a98ed35-7065-4099-aefc-6d22e674ef55SPL set ID b1e7ebd4-d0d2-40a5-aa11-5f68bc5972bdRxCUI 861208UNII 4S9CL2DY2HUPC 0361314144058
Pharmacologic class: alpha-Adrenergic Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N461314014405 followed by a unit qualifier and the quantity

Package 61314-0144-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 24, 2025.

Indications (excerpt from the label)

Brimonidine tartrate ophthalmic solution, 0.15% is indicated for the lowering of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Brimonidine tartrate ophthalmic solution, 0.15% is an alpha adrenergic agonist indicated for the lowering of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension ( 1 ).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)